Valuation: Cencora, Inc.

Market Cap 60.29B 52.95B 49.25B 45.19B 84.91B 5,806B 86.22B 585B 228B 2,855B 226B 221B 9,870B P/E 2026 *
17.2x
P/E 2027 * 18.3x
Enterprise Value 64.67B 56.8B 52.83B 48.47B 91.08B 6,228B 92.48B 627B 245B 3,062B 243B 238B 10,587B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.18x
Free-Float
62.46%
Yield 2026 *
0.77%
Yield 2027 * 0.79%
1 day+1.84%
1 week+1.42%
Current month+9.86%
1 month+8.20%
3 months+3.66%
6 months-8.79%
Current year-4.98%
1 week 263.6
Extreme 263.6
272.2
1 month 246.8
Extreme 246.8
272.2
Current year 216.4
Extreme 216.4
320.9
1 year 216.4
Extreme 216.4
325.35
3 years 161.46
Extreme 161.46
325.35
5 years 137.06
Extreme 137.06
325.35
10 years 137.06
Extreme 137.06
325.35
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2024
Director of Finance/CFO 59 29/06/2026
Chief Tech/Sci/R&D Officer 50 04/11/2024
Director TitleAgeSince
Director/Board Member 75 16/05/2013
Director/Board Member 59 01/10/2024
Chairman 64 01/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+1.42% - - 59.35B
+2.29%+2.36%-17.97%-10.09% 175B
+1.46%+0.01%-9.87%-6.25% 105B
-1.13%-2.60%+26.37%+54.76% 50.71B
+2.22%-1.14%-14.85%-44.15% 42.15B
+2.98%-2.61% - - 31.82B
+1.50%-6.67%-17.52%-43.99% 27.2B
-7.67%-8.39%+17.59%-12.73% 25.11B
+1.63%-1.73%-5.80%-7.80% 20.53B
+0.30%-4.54%-16.61%-2.81% 19.42B
Average +0.54%-1.64%-4.83%-9.13% 55.27B
Weighted average by Cap. +1.23%-0.13%-8.49%-6.96%

Financials

2026 *2027 *
Net sales 337B 296B 275B 253B 474B 32,443B 482B 3,268B 1,277B 15,950B 1,265B 1,237B 55,148B 358B 314B 292B 268B 504B 34,479B 512B 3,473B 1,357B 16,951B 1,344B 1,315B 58,608B
Net income 3.47B 3.05B 2.84B 2.6B 4.89B 334B 4.96B 33.67B 13.15B 164B 13.03B 12.75B 568B 2.98B 2.62B 2.44B 2.24B 4.2B 287B 4.26B 28.92B 11.3B 141B 11.19B 10.95B 488B
Net Debt 4.38B 3.85B 3.58B 3.28B 6.17B 422B 6.26B 42.49B 16.6B 207B 16.45B 16.09B 717B 5.34B 4.69B 4.36B 4B 7.52B 514B 7.64B 51.79B 20.23B 253B 20.04B 19.61B 874B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
24/07/26 €271.80 +1.84%
23/07/26 €266.90 +1.25%
22/07/26 €263.60 -0.83%
21/07/26 €265.80 -0.26%
20/07/26 €266.50 -0.56%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
309.89USD
Average target price
355.83USD
Spread / Average Target
+14.83%

Quarterly revenue - Rate of surprise